Innovate UK Innovation Loans: R&D finance from £100,000 to £5 million

Innovate UK Innovation Loans finance late-stage research and development with a clear route to commercialisation. They are loans rather than grants, so the applicant must show both an innovative project and a business capable of paying interest and repaying the debt.

The 2026 programme now uses an open Expression of Interest route

Innovate UK's current Innovation Loans Expression of Interest opened on 6 June 2026 and has no submission deadline. UK-registered micro, small and medium-sized enterprises can submit an EOI for close-to-market innovative projects with strong commercial potential.

An approved EOI leads to an invitation for a full application. Businesses should use the live Innovation Funding Service rather than relying on deadlines from earlier competition rounds.

Loans can range from £100,000 to £5 million

Recent 2026 Innovation Loan competitions state that eligible projects can request between £100,000 and £5 million. Projects can run for up to five years including R&D and pre-commercialisation phases.

Do not request the maximum simply because it is available. The loan should match the project budget and the company's ability to service interest and later repay.

The applicant must be a UK-registered SME carrying out the project in the UK

Current competition guidance requires the applicant to be a UK-registered micro, small or medium-sized enterprise, carry out the project from or in the UK and intend to exploit the results in or from the UK.

Large companies, universities and charities cannot lead a standard Innovation Loan application under the current SME-only route.

The project must be genuinely innovative and close to market

Innovate UK targets late-stage experimental development with strong commercial potential rather than ordinary product maintenance or routine capital spending.

The application needs to show technical innovation, economic impact, market route and why public lending is needed. A normal software upgrade or equipment purchase is unlikely to fit just because the company calls it R&D.

Innovation assessment does not replace credit assessment

Innovate UK says applicants must demonstrate that the business is suitable to take on the loan, can cover interest and will be able to repay on time. The programme makes a credit decision as well as an innovation decision.

Prepare management accounts, forecasts, existing debt and cash runway alongside the project case. A strong invention inside a weak borrower can still fail the lending test.

Project start and first drawdown follow credit approval and documentation

Recent competition guidance says the exact project start and first drawdown depend on final credit committee approval and completion of loan documents. An award notification is therefore not the same as cash already in the bank.

Build bridge funding into the project plan if suppliers or staff costs arise before the first draw. Track loan proceeds separately from grant or revenue income.

Worked example: an SME requests £2 million for a four-year late-stage R&D and pre-commercialisation programme. The project budget can fit the programme, but the lender also wants evidence that the business can pay interest during development and repay after commercialisation. A technically strong application can still fail if the cash forecast assumes a product launch with no downside case.

Separate project finance from corporate runway. Innovation Loan proceeds can support eligible project activity, but the company still needs money for ordinary overhead, tax and any non-project work. A project that is fully funded can exist inside a company that still runs out of general cash.

Use the EOI process to test fit before investing heavily in a full application. Keep the latest competition guidance because Innovate UK changed programme design in 2026, including more flexibility around pre-commercial activity and higher maximum borrowing than older guidance described.

Build interest into project economics from the start. Innovation Loans can support long development periods, but interest still accumulates or becomes payable according to the facility terms. A product that reaches commercialisation two years late can therefore carry more financing cost than the original business case assumed.

Keep technical milestones and loan drawdowns connected. If later tranches depend on project progress or credit review, project leadership should know which deliverables unlock cash. Treasury should not schedule supplier commitments against a future draw that remains conditional.

Keep commercialisation assumptions linked to the repayment model. If the forecast says the new product reaches £10 million revenue in year three, the board should see what repayment looks like if revenue is only £4 million. Innovation debt is still safest when the business has a credible downside route to repayment.